APRICUS BIOSCIENCES, INC.·4

Nov 30, 6:54 PM ET

Martin Steven Robert 4

4 · APRICUS BIOSCIENCES, INC. · Filed Nov 30, 2012

Insider Transaction Report

Form 4
Period: 2012-11-30
Martin Steven Robert
Chief Financial Officer
Transactions
  • Award

    Stock Option (right to buy)

    2012-11-30+2,0832,083 total
    Exercise: $2.20Exp: 2022-11-30Common Stock (2,083 underlying)
Footnotes (1)
  • [F1]This option is fully vested as of the date of grant.

Documents

1 file
  • 4
    v329595_4.xmlPrimary

    OWNERSHIP DOCUMENT